Tech Company Financing Transactions
G1 Therapeutics Funding Round
G1 Therapeutics, based in Research Triangle Park, raised $33 million from Eshelman Ventures, RA Capital and Hatteras Venture Partners.
Transaction Overview
Eshelman Ventures (Lead Investor) (Fred Eshelman)
RA Capital (Lead Investor) (Peter Kolchinsky)
Hatteras Venture Partners (Christy Shaffer)
MedImmune Ventures (Ronald Laufer)
Company Information
Research Triangle Park, NC 27709
USA
Management Team
Browse more venture capital transactions:
Prev: 2/5/2015: ReShape Medical venture capital transaction
Next: 2/5/2015: Sauce Labs venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs